NCT06941441

PAH Exercise Study

Remotely-Monitored Exercise to Enhance Functional Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Initiating Sotatercept Therapy: A Single-site Feasibility Study

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: University of Washington · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Ten patients with PAH who are stable and eligible to initiate sotatercept therapy will participate in a 26 week study that consists of a 24-week intervention period where patients will receive complimentary sotatercept as prescribed, plus a tailored, progressive home exercise program with wrist-worn fitness tracker and oxygen saturation monitoring.

Conditions

• Pulmonary Arterial Hypertension (PAH)
• Exercise Therapy

Interventions

Type	Name	Description
OTHER	Home exercise program	A tailored, progressive home exercise program with wrist-worn fitness tracker and oxygen saturation monitoring

Timeline

• Start date: 2025-04-15
• Primary completion: 2026-09-30
• Completion: 2026-09-30
• First posted: 2025-04-23
• Last updated: 2025-04-23

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study